patent.fyi
Applications  /  US 2026/0355148
United States Patent Application Publication

US 2026/0355148 A1

Published
Nov 12, 2026
Filed
Jun 4, 2026
Earliest date on the face
Jun 9, 2025
Classification
A61K 31/37
First published here
Nov 19, 2026

Generated automatically. Not reviewed by a person. Not legal advice or an opinion.

Section 1 · machine-generated

What if?

Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.

1.1Thymol as the aromatic scaffold

What ifWhat if Ar is the aromatic residue of thymol?
Claim language“estrone, sesamol, vanillin, euparin”

Potassium carbonate generates thymol phenoxide in acetonitrile. The phenoxide displaces tosylate from fluoromethyl p-toluenesulfonate to form the O–CH2F ether on a ring bearing methyl and isopropyl groups.

1.1Guaiacol as the aromatic scaffold

What ifWhat if Ar is the aromatic residue of guaiacol?
Claim language“flavonoids, flavonols, chalcone, hydroxychalcone, dihydrochalcone”

Guaiacol provides one free phenolic hydroxyl group adjacent to a methoxy group. Base-promoted reaction with fluoromethyl p-toluenesulfonate converts the hydroxyl group to O–CH2F and gives adjacent methoxy and fluoromethoxy groups.

1.1Coumarin as the aromatic scaffold

What ifWhat if Ar is the aromatic residue of 7-hydroxycoumarin?
Claim language“estrone, sesamol, vanillin, euparin”

The phenoxide of 7-hydroxycoumarin reacts with fluoromethyl p-toluenesulfonate at the phenolic oxygen. The product carries an O–CH2F group at position 7 of the fused lactone scaffold.

Section 2 · machine-generated

Variations

Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.

Other field of use

Fluorinated tracer for polymer diffusion

The fluoromethyl ether of sesamol serves as a small-molecule tracer in a polymer film. The purified ether is blended into a solvent-cast cellulose acetate film, and the dried film is immersed in a stirred water–ethanol bath. Fluorine-19 nuclear magnetic resonance measurements of bath samples track tracer release over time.

Component substitution

Cesium carbonate as the reaction base

Cesium carbonate replaces potassium carbonate in the reaction of sesamol with fluoromethyl p-toluenesulfonate. The reactants and cesium carbonate are stirred in dry acetonitrile under reflux, where the base generates the phenoxide that forms the fluoromethyl ether. The mixture is cooled and filtered to remove inorganic solids before the filtrate is concentrated.

Acetone as the reaction solvent

Dry acetone replaces acetonitrile in the reaction of vanillin with fluoromethyl p-toluenesulfonate and potassium carbonate. A stirred flask fitted with a condenser holds the suspension at acetone reflux, approximately 56 °C at atmospheric pressure. Liquid chromatography tracks vanillin consumption, and filtration removes suspended solids before the solvent is evaporated.

Combination with existing systems

Reactor coupled to preparative liquid chromatography

A stirred reflux reactor feeds a solids filter and a solvent exchange vessel upstream of a preparative reversed-phase liquid chromatography system. The cooled reaction mixture passes through the filter, and the solvent exchange vessel concentrates the filtrate and dilutes it with the initial water–acetonitrile mobile phase. A fraction collector captures the fluoromethyl ether in the retention window established by an analytical run, and the collected fractions are concentrated under reduced pressure.

Automated or data-driven variant

Chromatography controls the reaction endpoint

A programmable controller connects a stirred reflux reactor to an automated liquid chromatography sampler through a filtered liquid sampling line. Every 15 minutes, the sampler withdraws an aliquot, dilutes it with mobile phase, and measures residual sesamol against an internal standard. The controller switches off the heater and starts jacket cooling after two consecutive samples show residual sesamol below 5% of its initial concentration.

Specific version of a part

Estrone with a C3 ether

Estrone provides a phenolic oxygen at carbon 3 of the steroid scaffold. The derivative bears O–CH2F at carbon 3 and retains the ketone at carbon 17.

Monohydroxychalcone with a para ether

A chalcone bearing a single para hydroxyl group on the carbonyl-side aromatic ring supplies the phenolic oxygen. Fluoromethylation gives a para O–CH2F substituent while retaining the conjugated enone between the two aromatic rings.

Section 3 · quoted from USPTO records

Other work

Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.

Document AUS 2005/0209313 A1
Published
Sep 22, 2005
Filed
Jul 1, 2002
Document BUS 7,507,423 B2
Published
Mar 24, 2009
Filed
Jan 11, 2001
Class
A61K 36/00
Claim 1
Document A
Document B
1.1Ar comprises: any of flavonoids, flavonols, chalcone, hydroxychalcone, dihydrochalcone, estrone, sesamol, vanillin, euparin.
Particular flavonoids for the purposes of the present invention include chalcones, dihydrochalones, aurones, flavanones, flavones, neoflavonoids, catechins, flavonols, dihydroflavonols, proanthocyanidins, flavans, flavan-3-ols and biflavonoids, their variously methoxylated and other modified forms such as conjugates, such as acyl conjugates and more specifically includes acacetin, apigenin, baicalein, chrysin, chrysoeriol, datiscetin, dihydrobinetin, dihydrokaempferol, diosme
A · US 2005/0209313 A1 · ¶ 16
Particular flavonoids for the purposes of the present invention include chalcones, dihydrochalones, aurones, flavanones, flavones, neoflavonoids, catechins, flavonols, dihydroflavonols, proanthocyanidins, flavans, flavan-3-ols and biflavonoids, their variously methoxylated and other modified forms such as conjugates, such as acyl conjugates and more specifically includes acacetin, apigenin, baicalein, chrysin, chrysoeriol, datiscetin, dihydrobinetin, dihydrokaempferol, diosme
B · US 7,507,423 B2 · ¶ 18

An empty cell means only that no passage was reproduced there.

Statements in these documents
More particularly, the present invention provides an efficient method of producing enriched flavonoid aglycones concentrates from plant material using aqueous solvents.
A · US 2005/0209313 A1 · ¶ 1
In addition, there is a strong demand for such materials to be free of organic solvent residues, particularly those that are industrially synthesised, and for products produced with minimum burden to the environment.
A · US 2005/0209313 A1 · ¶ 3
More particularly, the present invention provides an efficient method of producing enriched flavonoid aglycones extracts from plant material using aqueous solvents.
B · US 7,507,423 B2 · ¶ 1
In addition, there is a strong demand for such materials to be free of organic solvent residues, particularly those that are industrially synthesised, and for products produced with minimum burden to the environment.
B · US 7,507,423 B2 · ¶ 3
Cite aspatent.fyi, US 2026/0355148 A1, claim 1, first published 2026-11-19T08:28:42-05:00, https://patent.fyi/US20260355148/, SHA-256 10f35d6cf94483ea3a3312fa4a682d9dc70ee341f7eef1920ca4e46ccdda9a90
First published
Permanent addresshttps://patent.fyi/US20260355148/
Content fingerprint (SHA-256)10f35d6cf94483ea3a3312fa4a682d9dc70ee341f7eef1920ca4e46ccdda9a90
Methodv2026-11-18.2 · automated, not reviewed by a person
Correctionscorrections@patent.fyi